TP53 and B-cell chronic lymphocytic leukemia: Importantly, CLL cells carrying del17p13/TP53 point mutations were similarly sensitive to SEL24‐B489 as p53‐wild‐type cells (Figure 3D and E, Tables S1 and S3).